Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2005
03/17/2005US20050059113 Antibodies to M-CSF
03/17/2005US20050059093 Method for detecting modulators of Notch signalling
03/17/2005US20050059067 Using restriction fragment length polymorphism in tyrosine kinase varian t as diagnostic tool in detection of cell proliferative and inflammatory disorders
03/17/2005US20050058666 Method for treating pain by peripheral administration of a neuroptoxin
03/17/2005US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds
03/17/2005US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
03/17/2005DE69822327T2 Transdermales arzneistoff-abgabesystem für ein entzündungshemmendes analgetisches mittel enthaltend diclofenac diethylammonium salz, und verfahren zu dessen herstellung The transdermal drug-delivery system-containing medium for anti-inflammatory analgesic diclofenac diethylammonium salt, and process for its manufacture
03/17/2005DE10337863A1 Verwendung von Chromen-4-on-Derivaten The use of chromene-4-one derivatives
03/17/2005CA2536927A1 Guanidine derivatives
03/16/2005EP1514877A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
03/16/2005EP1514867A2 Substituted phenyl derivatives, their preparation and use
03/16/2005EP1514557A1 Preventives/remedies for bone and joint diseases
03/16/2005EP1514555A1 Polyherbal formulation for hepatic and splenic disorders
03/16/2005EP1514552A1 Novel fused imidazole derivative
03/16/2005EP1514551A1 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
03/16/2005EP1514549A1 Powdery respiratory tonic composition
03/16/2005EP1514541A1 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
03/16/2005EP1514539A2 Micro-encapsulated topical analgesic for pain relief and sleeve comprising it
03/16/2005EP1513942A2 Galactosyl isomalt, method for production and use thereof
03/16/2005EP1513870A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
03/16/2005EP1513862A2 Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders
03/16/2005EP1513844A1 Novel interleukin-1 beta converting enzyme inhibitors
03/16/2005EP1513839A1 3-substituted quinuclidines and their use
03/16/2005EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors
03/16/2005EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
03/16/2005EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
03/16/2005EP1513831A1 Novel compounds, their use and preparation
03/16/2005EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors
03/16/2005EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
03/16/2005EP1513821A1 Protein kinase inhibitors
03/16/2005EP1513820A2 Compounds, compositions, and methods
03/16/2005EP1513814A1 Novel piperidine compound
03/16/2005EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
03/16/2005EP1513806A1 New salts
03/16/2005EP1513589A1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
03/16/2005EP1513554A1 Cd16a binding proteins and use for the treatment of immune disorders
03/16/2005EP1513543A2 Fas peptide mimetics and uses thereof
03/16/2005EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
03/16/2005EP1513529A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
03/16/2005EP1513522A2 Methods of treating conditions associated with an edg receptor
03/16/2005EP1513520A2 Substituted pyrrolines as kinase inhibitors
03/16/2005EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES
03/16/2005EP1513495A1 Modified release pharmaceutical formulation
03/16/2005EP1513493A2 Analgesics
03/16/2005EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
03/16/2005EP1513403A1 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
03/16/2005EP1456241B1 Mono-and dual anti-cd4-rantes chemokine/cytokine constructs
03/16/2005EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
03/16/2005EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP1226119B1 Tyrosine kinase inhibitors
03/16/2005EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
03/16/2005EP1117296B1 Combination of bisphosphonate and tetracycline
03/16/2005CN1596263A Aryl fused azapolycyclic compounds
03/16/2005CN1596257A Novel crystalline compound
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them
03/16/2005CN1596247A Lactam derivatives as antagonists for human 11CBY receptors
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1596112A Benzothiazole derivatives
03/16/2005CN1594342A Glycosyl phthalic imidine compounds with anti-inflammatory activity
03/16/2005CN1594319A Process for extracting ginkgolide, ginkgolide injection and process for preparing same
03/16/2005CN1594311A Novel spiro compound bulbophyllispiradienone having activities of anti-cancer and inhibiting NO release and its derivatives
03/16/2005CN1593641A Externally applied ointment for treating pains of neck, shoulder, waist and limbs and its preparation process
03/16/2005CN1593639A Chinese medicine decoction for treating flaccidity syndrome
03/16/2005CN1593626A Orally disintegrating tablet of 'Xintongning' and its preparation
03/16/2005CN1593623A Orally disintegrating tablet of 'Tongxinluo' and its preparation
03/16/2005CN1593580A Pain relieving plaster for rheumathritis
03/16/2005CN1593576A Medicinal wine for expelling wind, eliminating dampness, relaxing tendon and stopping pain
03/16/2005CN1593552A Multifunctional externally applied botanical liquid
03/16/2005CN1593527A Dispersible tablet of 'Duyiwei' and its preparing method
03/16/2005CN1593510A Method for preparing Chinese medicinal formulation of dog button
03/16/2005CN1593488A Compound medicinal powder for dredging stagnate meridians
03/16/2005CN1593484A Bone strengthening granule of tortoise plastron and astragalus root
03/16/2005CN1593474A Chinese medicine composition for treating lumbago and scelalgia and hyperosteogeny and its preparing method
03/16/2005CN1593464A Healthy product extracted from barnacle and its preparation process
03/16/2005CN1593429A Novel oral guacetisal solid preparation and its preparing method
03/16/2005CN1593428A Dextran-aspirin combined medicine and its preparation method
03/16/2005CN1593389A Cool plaster and its processing method and usage
03/16/2005CN1193026C Z-pyrazoline-5-ones
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1193003C Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha
03/16/2005CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
03/16/2005CN1192773C Cyclic amine CCR3 antagonisis
03/16/2005CN1192771C Medicine for treating rheumatism and rheumatoid disease
03/16/2005CN1192767C Capsule and binding agent for pharmaceutical formulations with improved storage stability
03/15/2005US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867221 Cyclic amine compounds and pharmaceutical composition containing the same
03/15/2005US6867214 Quinazoline derivatives and pharmaceutical applications thereof
03/15/2005US6867213 Vitronectin receptor inhibitors; bone diseases, osteoporosis; esterification of acid form with isopropanol
03/15/2005US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release
03/15/2005US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/15/2005US6867192 Inhibiting eosinophil infiltration into lungs; such as 2-((-2-((2-(2-Benzoylphenoxy)acetyl)amino)-4-methylpentanoyl)-amino)-3-(4 -(((4-((2-phenylacetyl)amino)-1-piperidinyl)-carbonyl)oxy)phenyl)propanoic acid